Open House Original Discount Contracts for Pharmaceuticals 2025-17

The Techniker Krankenkasse (TK) aims to establish discount contracts with all suitable pharmaceutical companies for the combination of active ingredients Beclometasone, Formoterol, and Glycopyrronium (ATC: R03AL09) under Section 130a (8) of the Social Code Book V. The contract will be concluded as part of TK's Open House Original procedure: individual negotiations on contract terms will not be conducted, and uniform conditions will apply. TK does not guarantee exclusivity to any individual contracting partner. The contract duration is a maximum of 24 months, starting from July 1, 2025, and will end no later than June 30, 2027, regardless of the contract conclusion date. If the patent expires or market exclusivity ends before the aforementioned end date, the contract will automatically terminate at the end of the month of patent expiration or market exclusivity. Participation in this Open House Original procedure is possible at any time during the contract duration. Due to existing industrial property rights concerning the active ingredient or the combination of active ingredients in question, the participation and contract documents will only be made available to those pharmaceutical companies that offer or intend to market medicines with the specified active ingredient or combination during the contract duration. The stated binding period is not relevant in this context and is solely due to the mandatory requirements of the form. All further information can be found in the participation and contract documents.